Schistosomiasis in the People's Republic of China: Prospects and challenges for the 21st century

Clinical Microbiology Reviews

Volumn 14, Issue 2, 2001, Pages 270-295

  Ross, A G P ^a   Sleigh, A C ^a   Li, Y ^a   Davis, G M ^a   Williams, G M ^a   Jiang, Z ^a   Feng, Z ^a   McManus, D P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; SCHISTOSOMA VACCINE;

ARTICLE; ASCITES; CATTLE DISEASE; CHEMOPROPHYLAXIS; CHINA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DISEASE TRANSMISSION; ENDEMIC DISEASE; FEVER; GENETIC SUSCEPTIBILITY; GROWTH RETARDATION; HEADACHE; HEPATOSPLENOMEGALY; HUMAN; IMMUNITY; INFECTION CONTROL; LETHARGY; PORTAL HYPERTENSION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SERODIAGNOSIS;

ANIMALS; CHINA; HOST-PARASITE RELATIONS; HUMANS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SNAILS;

BOS TAURUS; JAPONICA; MAMMALIA; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TREMATODA;

EID: 0035067389     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.2.270-295.2001     Document Type: Article

References (228)

1. A report on the association of colonic cancer with Schistosoma japonicum infection
2. Evidence for the segregation of a major gene in human susceptibility/ resistance to infection by Schistosoma mansoni
3. Genetic epidemiology of infectious diseases in humans: Design of population-based studies
4. DNA vaccines: Technology and application as anti-parasite and antimicrobial agents
5. The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells
6. An experimental approach to the pathogenesis of pipestem fibrosis (Symmers' fibrosis of the liver)
7. Large cerebral infarction during praziquantel therapy in neurocysticercosis
8. Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen
9. Schistosomiasis
10. Modeling the transmission of schistosomiasis: An introductory view
11. Implications of faecal egg count variation when using the Karo Katz method to assess S. mansoni infections
12. Effect of neonatal injection of anti-antibodies on immunity to schistosomes (Schistosoma mansoni) in the rat
13. Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni
14. Resistance against Schistosoma mansoni induced by highly irradiated infections: Studies on species specificity of immunization and attempts to transfer resistance
15. The morbidity attributable to S. japonicum infection in 3 villages in the Dongting lake region, Hunan province, China
16. Networking on Schistosomiasis japonica
17. Schistosoma mansoni: IL-4 is necessary for concomitant immunity in mice
18. Immunity in human schistosomiasis
19. Immunological aspects of human schistosomiasis
20. Studies on ultrasonographic diagnosis of schistosomiasis japonica in China - A review of selected Chinese studies
21. Changes of ultrasonography and two serum biochemical indices for hepatic fibrosis in schistosomiasis japonica patients one year after praziquantel treatment
22. Effector and regulatory mechanisms in immunity to schistosomes: A heuristic view
23. Immunoglobulin E and effector cells in schistosomiasis
24. Comparison of Th1 and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae
25. Schistosoma japonicum: Migration of adult worm pairs in mesenteric veins of mice
26. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis
27. Differential regulation of granuloma size and hepatic fibrosis in schistosome infections
28. Progress and problems in schistosomiasis control in China
29. Relative distribution of Schistosoma japonicum eggs in the intestine of man: A subject of inconsistencies
30. Progress in schistosomiasis control in China
31. Schistosomiasis control program in the People's Republic of China: A review
32. Progress in the assessment of morbidity due to Schistosoma japonicum infection: A review of recent literature
33. Schistosomiasis control in China
34. Granulomatous disease of large intestine secondary to schistosome infection: A study of 229 cases
35. The imaging diagnosis of hepatic schistosomiasis japonica sequelae
36. Mid-term assessment of health education on schistosomiasis control in Hunan province
37. Oncomelania hupensis (Gastropoda: Hydrobiidae): Hybridization, genetics, and transmission of Schistosoma japonicum
38. Snail hosts of Asian Schistosoma infecting man: Origin and coevolution
39. Evolution of prosobranch snails transmitting Asian Schistosoma; coevolution with Schistosoma: A review
40. Population genetics and systematic status of Oncomelania hupensis (Gastropoda: Pomatiopsidae) throughout China
41. Cytochrome oxidase 1-based phylogenetic relationships among the Pomatiopsidae, Hydrobiidae, Rissoidae and Truncatellidae (Gastropoda: Caenogastropoda: Rissoacea)
42. Allozyme analyses test the taxonomic relevance of ribbing in Chinese Oncomelania (Gastropoda: Rissoacea: Pomatiopsidae)
43. Snail-Schistosoma, Paragonimus interactions in China: Population ecology, genetic diversity, coevolution and emerging diseases
44. Epidemiology and control of cattle schistosomiasis
45. Resistance to Schistosoma mansoni in humans: Influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy
46. Human resistance to schistosomiasis is associated with IgG reactivity to a 37-kDa larval surface antigen
47. Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni
48. A model for variations in single and repeated egg count in Schistosoma mansoni infections
49. Day-to-day variation and circadian rhythm of egg excretion in urinary schistosomiasis in the Sudan
50. A vaccine for schistosomiasis: Alternative approaches
51. Reversal of advanced liver fibrosis in rabbits with schistosomiasis japonica
52. Immunity after treatment of human schistosomiasis: Association between IgE antibodies to adult worms and resistance to reinfection
53. Passively transferable protection against Schistosoma japonicum induced in the mouse by multiple vaccination with attenuated larvae: The development of immunity, antibody isotype responses and antigen recognition
54. Isolation of T-cell antigens by using a recombinant protein library and its application to the identification of novel vaccine candidates against schistosomiasis
55. Schistosoma mansoni infection in IgE-producing and IgE-deficient mice
56. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobia
57. Generation, identification, and evaluation of expressed sequence tags from different developmental stages of the Asian bloodfluke Schistosoma japonicum
58. The behavioural pattern of social and religious water-contact activities in the Egypt-49 bilharziasis project area
59. Studies on schistosomiasis japonica
60. Water-contact observations in Kenya communities endemic for schistosomiasis: Methodology and patterns of behaviour
61. Puberty and age-related changes in susceptibility to schistosome infection
62. Drug treatment of neurocysticercosis
63. Drug resistance in human helminths: Current situation and lessons from livestock
64. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase
65. High-affinity IgE receptor on eosinophils is involved in defence against parasites
66. Repeated community-based chemotherapy for control of Schistosoma mansoni: Effect of screening and selective treatment on prevalence and intensities of infection
67. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies
68. IgA antibodies to a protective antigen in human schistosomiasis mansoni
69. Collaborative study on evaluation of immunodiagnostic assays in schistosomiasis japonica by treatment efficacy assessment
70. Molecular identification of a 21.7 kDa Schistosoma japonicum antigen as a target of human IgE response
71. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium
72. On the mathematical analysis of schistosome populations
73. Intestinal helminths of man: The interpretation of egg counts
74. Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma mansoni
75. Glycine-valine dimorphism at the 86th amino acid of HLA-DRB1 influenced the prognosis of postschistosomal hepatic fibrosis
76. HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population
77. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni
78. Recombinant vaccinia viruses and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain used in a murine immunization-challenge model
79. Schistosomiasis and the social patterning of infection
80. Human water contact activities related to the transmission of bilharziasis (schistosomiasis)
81. Resettlement for China's Three Gorges Dam: Socio-economic impact and institutional tensions
82. CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling
83. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell and IFN-y-dependent effector mechanisms
84. The use of diagnosis ultrasound in schistosomiasis - Attempts at standardization of methodology
85. Adult resistance to schistosomiasis mansoni: Age-dependence of reinfection remains constant in communities with diverse exposure patterns
86. Schistosomiasis of the central nervous system: Experiences in World War II and review of literature
87. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: Clinical, ultrasonographical and biochemical parameters
88. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni
89. IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection
90. Drugs five years later: Praziquantel
91. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium
92. Mitochondrial DNA sequences of human schistosomes: The current status
93. Construction and characterization of a Schistosoma mansoni bacterial artificial chromosome library
94. Evaluation of a monoclonal antibody-based sandwich ELISA for detection of circulating S. japonicum antigen (Sj31/32) in an endemic area of China
95. A multivariate analysis of the relationship between the workability and S. japonicum infection in China
96. The serological differentiation of acute and chronic S. japonicum infection by ELISA using keyhole limpet haemocyanin as antigen
97. The serological diagnosis of Schistosoma japonicum infection in China: The dot-ELISA technique employing keyhole limpet haemocyanin as the specific antigen
98. A 2-year prospective study in China provides epidemiological evidence for resistance in humans to re-infection with Schistosoma japonicum
99. Two year impact of praziquantel for Schistosoma japonicum infection in China: Re-infection, sub-clinical disease and fibrosis marker measurements
100. Epidemiology of Schistosoma japonicum in China: Morbidity and strategies for control in the Dongting Lake region
101. Subspecific differentiation of oncomelanid snails
102. A case of dysentery in Hunan province caused by the trematode Schistosoma japonicum
103. Experimental study on self-cure phenomenon in water buffaloes infected with Schistosoma japonicum
104. Observation of the self-cure phenomenon in water buffaloes infected with Schistosoma japonicum
105. The dynamics of helminth infections with special reference to schistosomes
106. Studies on the emergence of cercariae of Schistosoma japonicum from their Chinese snail host, Oncomelania hupensis
107. Recent progress in the control of schistosomiasis in China
108. Schistosomiasis control in the People's Republic of China
109. Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: Correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific T cells
110. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33
111. Possible associations of rectal carcinoma with Schistosoma japonicum infection and membranous nephropathy: A case report with a review
112. Child growth, nutritional status and schistosomiasis japonica in Jiangxi, People's Republic of China
113. The search for a vaccine against schistosomiasis - A difficult path but an achievable goal
114. A vaccine against Asian schistosomiasis: The story unfolds
115. Production of interleukin-10 by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum
116. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis
117. Studies on the sex ratio of worms in schistosome infections
118. Anti-embryonation immunity in murine schistosomiasis japonica (Philippines)
119. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: Evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression
120. The induction of specific immunity against Schistosoma japonicum by exposure of mice to ultraviolet attenuated cercariae
121. The strain specificity of vaccination with ultraviolet attenuated cercariae of the Chinese strain of Schistosoma japonicum
122. Antibody is responsible for the passive transfer of immunity to mice from rabbits, rats or mice vaccinated with attenuated S. japonicum cercariae
123. Septa in the liver of patients with chronic hepatic schistosomiasis japonica: MR appearance
124. Schistosomiasis japonica in American military personnel: Clinical studies of 600 cases during the first year after infection
125. Further evidence suggesting the presence of a locus on human chromosome 5q31-q33 influencing the intensity of infection with Schistosoma mansoni
126. Studies on Schistosomiasis japonica in New China
127. Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: Influence of infection duration, infection intensity, and host age
128. Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary school-children
129. Selectin and Lewis(x) are required as co-receptors in antibody-dependent cell-mediated cytotoxicity of human eosinophils to Schistosoma mansoni schistosomula
130. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons
131. Ultrasonographic and serologic abnormalities in Schistosoma japonicum infection in Leyte, the Philippines
132. Immunity and morbidity in schistosomiasis japonica infection
133. Relationship of prevalence and intensity of infection to morbidity in schistosomiasis japonica: A study of three communities in Leyte, Philippines
134. Schistosomiasis japonica in the Philippines: The long-term impact of population-based chemotherapy on infection, transmission, and morbidity
135. The involvement of Th1/2 cytokines in protective immunity against Schistosoma japonicum infection
136. The immunology of schistosomiasis
137. Functional dichotomy in the CD4+ T cell response to Schistosoma mansoni
138. Side effects of praziquantel in the treatment of Schistosoma mansoni in Maniema, Zaire
139. Bordetella Pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally
140. Dot-dye-immunoassay and dot-ELISA for the serological differentiation of acute and chronic schistosomiasis mansoni using keyhole limpet haemocyanin as antigen
141. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels
142. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area
143. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes
144. Schistosomiasis control in the People's Republic of China
145. Epidemiologic features of Schistosoma japonicum among fishermen and other occupational groups in the Dongting Lake region (Hunan Province) of China
146. Faecal egg aggregation in humans infected with Schistosoma japonicum in China
147. Activity diaries to assess human water contact patterns for schistosomiasis japonica in the Dongting Lake region of China. I. A comparison with other exposure instruments
148. Dam worms
149. Activity diaries to assess human water contact patterns for schistosomiasis japonica in the Dongting Lake region of China. II. Activity diaries and path analysis to predict infection
150. Epidemiologic identification of Chinese individuals putatively susceptible or insusceptible to Schistosoma japonicum: A prelude to immunogenetic study of human resistance to Asian schistosomiasis
151. Is there immunity to Schistosoma japonicum?
152. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: Similarity of IgE-binding epitopes to allergen peptides
153. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201
154. Serum procollagen peptides and collagen VI for the assessment of activity and degrees of hepatic fibrosis in schistosomiasis and alcoholic liver disease
155. Review and suggestions of control of animal schistosomiasis in China
156. Schistosoma japonicum: An ultraviolet-attenuated cercarial vaccine applicable in the field for water buffaloes
157. Immunization of pigs against infection with Schistosoma japonicum using ultraviolet-attenuated cercariae
158. Schistosoma japonicum: Purification and diagnostic application of recombinant 32kD antigen
159. Three-year prospective study of the evolution of Manson's schistosomiasis in North-East Brazil
160. Schistosomiasis
161. Manson's schistosomiasis in Brazil: 11-year evaluation of successful disease-control with oxamniquine
162. Public health and public choice: Dammed off at China's Three Gorges
163. Eradication of schistosomiasis in Guangxi, China. 1. Setting, strategies, operations and outcomes, 1953-1992
164. Eradication of schistosomiasis in Guangxi, China. 2. Political economy, management strategy and costs, 1953-92
165. The parasites and their life cycles
166. Note on a new form of liver cirrhosis due to the presence of ova of Bilharzia haematobia
167. The use of diagnostic ultrasound in schistosomiasis - Attempts at standardization of methodology
168. Randomized controlled trial of oral artemether for the prevention of Schistosoma mansoni infection
169. Recognition of schistosome glycolipids by immunoglobulin E: Possible role in immunity
170. The course of seizures after treatment for cerebral cysticercosis
171. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni
172. Schistosomiasis vaccine development - The current picture
173. Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population
174. A rapid one-step method of EIA for detection of circulating antigen of Schistosoma japonicum
175. The pathology of schistosome infections
176. Praziquantel in treatment of cerebral schistosomiasis
177. Bloody diarrhoea after praziquantel therapy
178. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment
179. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines
180. Studies on the detection of specific IgG subclasses and its evaluation of therapeutic efficacy in Schistosoma japonicum
181. Morbidity due to schistosomiasis japonica in the People's Republic of China
182. Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China
183. Erhaia (Gastropoda:Rissooidea): Phylogenetic relationships and the question of Paragonimus coevolution in Asia
184. Genetics of the susceptibility to infectious diseases (First Louis Pasteur Conference on Infectious Disease)
185. Resistance to reinfection after treatment of urinary schistosomiasis
186. Helminth genome analysis: The current status of the filarial and schistosome genome projects
187. Why don't we have a schistosomiasis vaccine?
188. Immune responses to the radiation-attenuated schistosome vaccine: What can we learn from knock-out mice?
189. Role of interleukin-7 in the relation between Schistosoma mansoni and its definitive vertebrate host
190. Reinfection with Schistosoma japonicum after treatment with praziquantel in the Poyang Lake region, China
191. A quantitative assay to detect circulating fibrosin and its application in experimental schistosomiasis
192. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia
193. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
194. IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic diseases
195. Early treatment of schistosomal infection with artemether and praziquantel in rabbits
196. Field studies on the preventive effect of oral artemether against schistosomal infection
197. Preventive effect of artemether in experimental animals infected with Schistosoma mansoni
198. Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits
199. The prophylactic effects of artemether against Schistosoma japonicum infections
200. Observation on collecting Oncomelania hupensis when opening the sluices during flood season in Yangtze River
201. Relationship between sluicing for irrigation and spreading of Oncomelania hupensis in Huhei Province
202. Clinical evaluation of praziquantel treatment of Schistosomiasis japonica
203. Experimental observation on the prevention of snail spreading by reverse siphoning
204. A collaborative study on the detection of circulating antigens in Schistosomiasis japonica
205. Collaborative study on antigens and methods for immunodiagnosis of schistosomiasis in China
206. Epidemic situation and strategies for schistosomiasis control in marshland and lake regions
207. Epidemiological features and control of schistosomiasis japonica in China
208. Epidemiological features and control strategies of schistosomiasis japonica in China
209. Snail distribution and susceptible zones of schistosomiasis in endemic areas around Poyang Lake
210. Studies on snail ecology in the marshlands of Poyang Lake region
211. Schistosoma japonicum myosin: Cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5
212. Vaccination of mice with gamma-irradiated Schistosoma japonicum cercariae
213. A brief introduction to nation-wide sampling survey on schistosomiasis
214. Kato-Katz stool examinations in schistosomiasis control of China
215. Transmission factors of schistosomiasis japonica in the mountainous regions with type of plateau canyon and plateau basin
216. Influence of livestock husbandry on schistosomiasis transmission in mountainous regions of Yunnan province
217. Schistosomiasis control in China
218. Diagnosis of schistosomiasis japonica in Chinese schoolchildren by administration of a questionnaire